Decreased facilitation by angiotensin II of noradrenergic neurotransmission in isolated mesenteric artery of rabbits with chronic heart failure

Journal of Cardiovascular Pharmacology

Volumn 41, Issue 3, 2003, Pages 356-362

  Balt, Jippe C ^a,b   Belterman, Charly N W ^a   Mathy, Marie Jeanne ^a   Nap, Alexander ^a   Baartscheer, Anton ^a   Pfaffendorf, Martin ^a   Van Zwieten, Pieter A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Angiotensin II; Angiotensin II type 1 receptor; Eprosartan; Rabbit mesenteric artery; Sympathetic neurotransmission

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; EPROSARTAN; HEPARIN; NORADRENALIN;

ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ELECTRIC FIELD; HEART FAILURE; MALE; MESENTERIC ARTERY; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANIMALS; CHRONIC DISEASE; ELECTRIC STIMULATION; HEART FAILURE, CONGESTIVE; MALE; MESENTERIC ARTERIES; NEURAL INHIBITION; NOREPINEPHRINE; RABBITS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; SYNAPTIC TRANSMISSION; VASOCONSTRICTION;

EID: 0037369561     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200303000-00003     Document Type: Article

References (37)

1. Mancia G. Sympathetic activation in congestive heart failure. Eur Heart J. 1990;11(suppl A):3-11.
2. Rector TS, Olivari MT, Levine TB, et al. Predicting survival for an individual with congestive heart failure using the plasma norepinephrine concentration. Am Heart J. 1987;114(1 part 1):148-52.
3. Benedict CR, Shelton B, Johnstone DE, et al. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation. 1996;94:690-7.
4. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med. 1987;316:1429-35.
5. Pfeffer MA, Pfeffer JM, Steinberg C, et al. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 1985;72:406-12.
6. Richer C, Fornes P, Cazaubon C, et al. Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats. Cardiovasc Res. 1999;41:100-8.
7. Reid IA. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol. 1992;262(6 part 1):E763-78. Editorial.
8. Swedberg K, Eneroth P, Kjekshus J, et al. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990;82:1730-6.
9. Crozier I, Ikram H, Awan N, et al. Losartan in heart failure: hemodynamic effects and tolerability. Losartan Hemodynamic Study Group. Circulation. 1995;91:691-7.
10. Gottlieb SS, Dickstein K, Fleck E, et al. Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation. 1993;88(4 part 1):1602-9.
11. Houghton AR, Harrison M, Cowley AJ. Haemodynamic, neurohumoral and exercise effects of losartan vs. captopril in chronic heart failure: results of an ELITE trial substudy: evaluation of Losartan in the Elderly. Eur J Heart Fail. 1999;1:385-93.
12. Grassi G, Cattaneo BM, Seravalle G, et al. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation. 1997;96:1173-9.
13. Murakami H, Liu JL, Zucker IH. Angiotensin II blockade [corrected] enhances baroreflex control of sympathetic outflow in heart failure. Hypertension. 1997;29:564-9.
14. Balt JC, Mathy MJ, Nap A, et al. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery. J Cardiovasc Pharmacol. 2001;38:141-8.
15. Balt JC, Mathy MJ, Pfaffendorf M, et al. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan. J Hypertens. 2001;19:2241-50.
16. Bril A, Forest MC, Gout B. Ischemia and reperfusion-induced arrhythmias in rabbits with chronic heart failure. Am J Physiol. 1991;261(2 part 2):H301-7.
17. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
18. Vermeulen JT, McGuire MA, Opthof T, et al. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts. Cardiovasc Res. 1994;28:1547-54.
19. Opthof T, Coronel R, Rademaker HM, et al. Changes in sinus node function in a rabbit model of heart failure with ventricular arrhythmias and sudden death. Circulation. 2000;101:2975-80.
20. Stephens N, Drinkhill MJ, Hall AS, et al. Structure and in vitro function of human subcutaneous small arteries in mild heart failure. Am J Physiol. 1998;274(5 part 1):C1298-305.
21. Bristow MR. Changes in myocardial and vascular receptors in heart failure. J Am Coll Cardiol. 1993;22(4 suppl A):61A-71A.
22. 2-adrenoceptor stimulation in patients with congestive heart failure. Circulation. 1994;90:17-22.
23. Mulder P, Compagnon P, Devaux B, et al. Response of large and small vessels to alpha and beta adrenoceptor stimulation in heart failure: effect of angiotensin converting enzyme inhibition. Fundam Clin Pharmacol. 1997;11:221-30.
24. Purdy RE, Weber MA. Angiotensin II amplification of alpha-adrenergic vasoconstriction: role of receptor reserve. Circ Res. 1988;63:748-57.
25. Laher I, Thompson LP, Gagne L. Protein kinase C as a modulator of response amplification in vascular smooth muscle. Blood Vessels. 1990;27:333-40.
26. Hughes J, Roth RH. Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol. 1971;41:239-55.
27. Guimaraes S, Paiva MQ, Moura D. Different receptors for angiotensin II at pre- and postjunctional level of the canine mesenteric and pulmonary arteries. Br J Pharmacol. 1998;124:1207-12.
28. Wollert KC, Drexler H. The renin-angiotensin system and experimental heart failure. Cardiovasc Res. 1999;43:838-49.
29. Regitz-Zagrosek V, Auch-Schwelk W, Neuss M, et al. Regulation of the angiotensin receptor subtypes in cell cultures, animal models and human diseases. Eur Heart J. 1994;15(suppl D):92-7.
30. Gunther S, Gimbrone MA Jr, Alexander RW. Regulation by angiotensin II of its receptors in resistance blood vessels. Nature. 1980;287:230-2.
31. Crespo MJ. Vascular alterations during the development and progression of experimental heart failure. J Card Fail. 1999;5:55-63.
32. Okumura Y, Nasa Y, Sanbe A, et al. Effects of long-term treatment with trandolapril on augmented vasoconstriction in rats with chronic heart failure. J Card Fail. 1996;2:301-10.
33. Porsa E, Freeman GL, Herlihy JT. Tachycardia heart failure alters rabbit aortic smooth muscle responsiveness to angiotensin II. Am J Physiol. 1994;266(3 part 2):H1228-32.
34. Newby DE, Goodfield NE, Flapan AD, et al. Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II. Heart. 1998;80:134-40.
35. Minatoguchi S, Majewski H. Modulation of norepinephrine release in adriamycin-induced heart failure in rabbits: role of presynaptic alpha 2-adrenoceptors and presynaptic angiotensin II receptors. J Cardiovasc Pharmacol. 1994;23:438-45.
36. Kawai H, Stevens SY, Liang CS. Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure. Am J Physiol Heart Circ Physiol. 2000;279:H3012-9.
37. Vanhoutte PM. Endothelium-dependent responses in congestive heart failure. J Mol Cell Cardiol. 1996;28:2233-40.